Sugi Predict

Sugi Predict / Compounds / SCHEMBL3374235

SCHEMBL3374235

SCHEMBL3374235

NC(=S)c1ccc2c(c1)OCO2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ PRKCI P41743 1/20 0.58
▸ HPGD P15428 4/20 0.57
▸ MAPT P10636 3/20 0.57
▸ MAOB P27338 1/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ NPC1 O15118 2/20 0.56
▸ TSHR P16473 1/20 0.52
▸ SRD5A2 P31213 1/20 0.51
▸ CASP3 P42574 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ SENP7 Q9BQF6 1/20 0.51
▸ GAA P10253 2/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ HDAC3 O15379 1/20 0.50
▸ HDAC4 P56524 1/20 0.50
▸ HDAC1 Q13547 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16526944 0.88 PRKCI (0.68) ALDH1A1PRKCIHPGDMAPTSMN1; SMN2
SCHEMBL16527203 0.86 PRKCI (0.66) ALDH1A1MAPK1PRKCIHPGDMAPT
SCHEMBL31378097 0.82 ALDH1A1 (0.66) ALDH1A1MAPK1HPGDMAPTMAOB
SCHEMBL57650 0.80 TSHR (0.79) ALDH1A1MAPK1HPGDMAPTSMN1; SMN2
SCHEMBL2968032 0.80 PLAU (0.58) ALDH1A1MAPK1HPGDMAPTMAOB
Hydrochloric Acid SCHEMBL3102294 0.78 PLAU (0.57) ALDH1A1MAPK1HPGDMAPTMAOB
Hydrochloric Acid SCHEMBL5013416 0.78 TSHR (0.76) ALDH1A1MAPK1HPGDMAPTMAOB
Hydrochloric Acid SCHEMBL30589973 0.78 TSHR (0.76) ALDH1A1MAPK1HPGDMAPTMAOB
SCHEMBL1581083 0.77 ALDH1A1 (0.55) ALDH1A1MAPK1MAPTSMN1; SMN2NPC1
SCHEMBL15139107 0.77 ALDH1A1 (0.55) ALDH1A1MAPK1MAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11970473-B2 Nootkatone derivatives and methods of using the same Arkansas State University—Jonesboro (US) 2024-04-30 — — US disclosed
US-20220324823-A1 NOOTKATONE DERIVATIVES AND METHODS OF USING THE SAME Arkansas State University - Jonesboro 2022-10-13 — — US disclosed
EP-1537091-B1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMMA AGONISTS HOFFMANN LA ROCHE (CH) 2010-10-06 — — EP disclosed
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 — — EP disclosed
CN-100360527-C CB 1 receptor inverse agonists HOFFMANN LA ROCHE (CH) 2008-01-09 — — CN disclosed
US-20070032518-A1 Compounds and methods of use AMGEN INC. (US) 2007-02-08 — — US disclosed
US-7135488-B2 Pyrrolyl-thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-14 — — US disclosed
US-20060241151-A1 Pyrid-2-one derivatives and methods of use AMGEN, INC. (US) 2006-10-26 — — US disclosed
CN-1735611-A CB 1 receptor inverse agonists HOFFMANN LA ROCHE (CH) 2006-02-15 — — CN disclosed
EP-1217001-B1 QUINUCLIDINE COMPOUNDS AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT EISAI CO LTD (JP) 2005-12-07 — — EP disclosed
US-20040110807-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2004-06-10 — — US disclosed
US-20040097555-A1 Concomitant drugs TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-05-20 — — US disclosed
EP-1402900-A1 MEDICINAL COMPOSITIONS Takeda Chemical Industries, Ltd. (JP) 2004-03-31 — — EP disclosed
EP-1354603-A1 CONCOMITANT DRUGS Takeda Chemical Industries, Ltd. (JP) 2003-10-22 — — EP disclosed
WO-2003066630-A2 QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS AMGEN INC. (US) 2003-08-14 — — WO disclosed
US-6599917-B1 A squalene-synthesizing enzyme inhibitor, a cholesterol biosynthesis inhibitor and a triglyceride biosynthesis inhibitor EISAI CO., LTD. (JP) 2003-07-29 — — US disclosed
EP-1217001-A1 QUINUCLIDINE COMPOUNDS AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT Eisai Co., Ltd. (JP) 2002-06-26 — — EP disclosed
EP-1205478-A1 p38MAP KINASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2002-05-15 — — EP disclosed
US-4197306-A CONTROL OF INSECTS AND ACARIDS UNIROYAL, INC. (US) 1980-04-08 — — US disclosed
US-4153703-A Method of controlling insects and acarids with certain aryl-substituted thiazoles UNIROYAL, INC. (US) 1979-05-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11970473-B2 Nootkatone derivatives and methods of using the same SDHA, PCK2, GOT2 ALDH1A1 1482/4885MAPK1 4379/4885PRKCI 2641/4885
US-20040097555-A1 Concomitant drugs TNF, CHUK, CNKSR1 ALDH1A1 3292/4885MAPK1 5/4885PRKCI 633/4885
US-20070032518-A1 Compounds and methods of use BAX, BAD, CASP3 ALDH1A1 282/4885MAPK1 1688/4885PRKCI 1684/4885
US-20040110807-A1 Thiazole derivatives SLC5A1, GPR119, INSR ALDH1A1 274/4885MAPK1 721/4885PRKCI 2826/4885
US-20220324823-A1 NOOTKATONE DERIVATIVES AND METHODS OF USING THE SAME SDHA, PCK2, GOT2 ALDH1A1 1482/4885MAPK1 4379/4885PRKCI 2641/4885
US-20060241151-A1 Pyrid-2-one derivatives and methods of use PLPBP, PNPO, PDXK ALDH1A1 490/4885MAPK1 718/4885PRKCI 2657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.